The fact this stock holds some mystery adds value (like unopened trading cards in the 90's). There's no "pumping" of this stock going on. The stats on it are very good. I spent a few minutes playing with the buy & ask the other day. If a little trader like me can change it 5 times in a row... imagine what a MM can do? Kalvista appears to have a promising drug on the way also. They've already said they're going to change the symbol in the future to correspond with their company. The fact that it has over 50% inside ownership is also promising. They could easily raise the PPS with a simple news release but they choose not to, perhaps there's still buying on their end? That makes sense considering they're holding over half the shares. CBYL appears to hold great potential for the right type of investor IMO...may be a long rough ride to the top!
Recent KALV News
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 08/22/2024 08:17:01 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 08/22/2024 08:13:56 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 08/22/2024 08:08:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/22/2024 01:26:19 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/22/2024 01:25:42 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/22/2024 01:25:05 AM
- KalVista Announces Validation of Marketing Authorization Application by the European Medicines Agency for Sebetralstat for Hereditary Angioedema • Business Wire • 08/15/2024 10:30:00 AM
- KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 08/02/2024 10:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/23/2024 08:23:36 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/16/2024 08:07:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/11/2024 08:59:46 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 07/11/2024 08:49:34 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 07/11/2024 08:11:22 PM
- KalVista Pharmaceuticals Provides Operational Update and Fiscal Year Financial Results • Business Wire • 07/11/2024 10:30:00 AM
- KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 07/02/2024 10:30:00 AM
- KalVista Initiates KONFIDENT-KID Trial for On-demand Treatment of Hereditary Angioedema Attacks with Sebetralstat in Children Aged 2 to 11 • Business Wire • 06/27/2024 10:30:00 AM
- KalVista Submits New Drug Application to FDA for Sebetralstat as First Oral On-demand Treatment for Hereditary Angioedema • Business Wire • 06/18/2024 10:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/10/2024 10:42:49 PM
- KalVista Pharmaceuticals Presents Data at Eastern Allergy Conference 2024 and the Japanese Dermatological Association 2024 • Business Wire • 06/06/2024 10:30:00 AM
- KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 06/04/2024 10:30:00 AM
- KalVista Pharmaceuticals Presents Data on Persisting Unmet Needs in Hereditary Angioedema at the European Academy of Allergy and Clinical Immunology (EAACI) Congress 2024 • Business Wire • 06/03/2024 10:30:00 AM
- KalVista Pharmaceuticals Announces New England Journal of Medicine Publishes Oral Sebetralstat Phase 3 Data Demonstrating its Potential to Transform the Treatment Landscape for People with Hereditary Angioedema • Business Wire • 05/31/2024 08:09:00 PM
- KalVista Pharmaceuticals Announces New England Journal of Medicine Publishes Oral Sebetralstat Phase 3 Data Demonstrating its Potential to Transform the Treatment Landscape for People with Hereditary Angioedema • Business Wire • 05/31/2024 04:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/24/2024 08:10:04 PM
FEATURED Element79 Gold Corp Provides Update on Nevada Portfolio • Aug 23, 2024 8:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Maybacks Adds Award Winning Show to Its Lineup Discusses Maybacks Opportunity • AHRO • Aug 22, 2024 11:30 AM
North Bay Resources Announces First Gold Concentrate at Mt. Vernon Gold Mine, Assays 12 oz/ton Gold, 17.5 oz/ton Platinum, and 8 oz./ton Silver, Sierra County, California • NBRI • Aug 22, 2024 10:28 AM
All Things Mobile Analytic, Inc. Reports Major Growth with Over $11 Million in Revenue • ATMH • Aug 22, 2024 7:19 AM
Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM